SuperworthArtiva Biotherapeutics shares outstanding ARTV
Diluted shares outstanding, averaged over each quarter, from 2023.
- Latest quarter, to Jun 30, 2026
- 39.4M
- On a year earlier
- +61.7%
- more shares
Artiva Biotherapeutics had 39.4M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 61.7% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 24.6M | +1% |
| FY2024 | 24.3M | +2901% |
| FY2023 | 809.3K | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 39.4M | +62% | |
| Q1 FY26 | 24.7M | +1% | |
| Q4 FY25 | 24.6M | +1% | |
| Q3 FY25 | 24.5M | +30% | |
| Q2 FY25 | 24.4M | +2905% | |
| Q1 FY25 | 24.3M | +2906% | |
| Q4 FY24 | 24.3M | +2901% | |
| Q3 FY24 | 18.9M | +171% | |
| Q2 FY24 | 811.2K | +1% | |
| Q1 FY24 | 809.8K | +2% | |
| Q4 FY23 | 809.3K | n/a | |
| Q3 FY23 | 7M | n/a |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Artiva Biotherapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.